Quick Answer
ENDRA Life Sciences Inc. reported Research And Development Expense of $1.85 million for the year ending 2025.
- ENDRA Life Sciences Inc. showed a decrease of -42.0% in Research And Development Expense from 2024 to 2025.
- This data is from ENDRA Life Sciences Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), ENDRA Life Sciences Inc.'s Research And Development Expense has grown by 273.5%.
- Historical annual values: Fiscal year 2025: $1.85 million | Fiscal year 2024: $3.19 million | Fiscal year 2023: $5.00 million | Fiscal year 2022: $6.55 million | Fiscal year 2021: $5.48 million | Fiscal year 2020: $5.92 million | Fiscal year 2019: $6.57 million | Fiscal year 2018: $4.72 million | Fiscal year 2017: $1.93 million | Fiscal year 2016: $495.4 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: